Ashish Sharma, Peter K. Kaiser, Ramin Tadayoni, Frank G. Holz, Luke Nicholson, Clara Vazquez-Alfageme, Sobha Sivaprasad, Taku Wakabayashi, Se Joon Woo, David Sarraf, Nilesh Kumar, Nikulaa Parachuri, Carl D. Regillo, Kourous A. Rezaei, Arshad M. Khanani, Francesco Bandello, Mahesh Shanamugam, Lalit Verma, Mangat Ram Dogra, Muralidhar NS, Manisha Agarwal, Anat Loewenstein, Baruch D. Kuppermann, International Retina Biosimilar Study Group (Inter BIOS Group)
{"title":"国际视网膜生物仿制药研究小组(Inter-BIOS Group)与印度玻璃体视网膜协会(VRSI)合作开展的《2023 年视网膜疾病抗血管内皮生长因子生物仿制药调查--印度》(Bio-INDAS)。","authors":"Ashish Sharma, Peter K. Kaiser, Ramin Tadayoni, Frank G. Holz, Luke Nicholson, Clara Vazquez-Alfageme, Sobha Sivaprasad, Taku Wakabayashi, Se Joon Woo, David Sarraf, Nilesh Kumar, Nikulaa Parachuri, Carl D. Regillo, Kourous A. Rezaei, Arshad M. Khanani, Francesco Bandello, Mahesh Shanamugam, Lalit Verma, Mangat Ram Dogra, Muralidhar NS, Manisha Agarwal, Anat Loewenstein, Baruch D. Kuppermann, International Retina Biosimilar Study Group (Inter BIOS Group)","doi":"10.1038/s41433-024-03284-x","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12125,"journal":{"name":"Eye","volume":"38 17","pages":"3392-3395"},"PeriodicalIF":3.2000,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI)\",\"authors\":\"Ashish Sharma, Peter K. Kaiser, Ramin Tadayoni, Frank G. Holz, Luke Nicholson, Clara Vazquez-Alfageme, Sobha Sivaprasad, Taku Wakabayashi, Se Joon Woo, David Sarraf, Nilesh Kumar, Nikulaa Parachuri, Carl D. Regillo, Kourous A. Rezaei, Arshad M. Khanani, Francesco Bandello, Mahesh Shanamugam, Lalit Verma, Mangat Ram Dogra, Muralidhar NS, Manisha Agarwal, Anat Loewenstein, Baruch D. Kuppermann, International Retina Biosimilar Study Group (Inter BIOS Group)\",\"doi\":\"10.1038/s41433-024-03284-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12125,\"journal\":{\"name\":\"Eye\",\"volume\":\"38 17\",\"pages\":\"3392-3395\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2024-08-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Eye\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.nature.com/articles/s41433-024-03284-x\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eye","FirstCategoryId":"3","ListUrlMain":"https://www.nature.com/articles/s41433-024-03284-x","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI)
期刊介绍:
Eye seeks to provide the international practising ophthalmologist with high quality articles, of academic rigour, on the latest global clinical and laboratory based research. Its core aim is to advance the science and practice of ophthalmology with the latest clinical- and scientific-based research. Whilst principally aimed at the practising clinician, the journal contains material of interest to a wider readership including optometrists, orthoptists, other health care professionals and research workers in all aspects of the field of visual science worldwide. Eye is the official journal of The Royal College of Ophthalmologists.
Eye encourages the submission of original articles covering all aspects of ophthalmology including: external eye disease; oculo-plastic surgery; orbital and lacrimal disease; ocular surface and corneal disorders; paediatric ophthalmology and strabismus; glaucoma; medical and surgical retina; neuro-ophthalmology; cataract and refractive surgery; ocular oncology; ophthalmic pathology; ophthalmic genetics.